Dr. Sandhya Bejjanki, M.D.
What this data tells you about Dr. Bejjanki
Dr. Sandhya Bejjanki is an internal medicine in Cleburne, TX, with 18 years in practice. Based on federal Medicare data, Dr. Bejjanki performed 35,656 Medicare services across 2,312 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bejjanki received a total of $1,615 from 36 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bejjanki is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 23,800 | $0 | $2 |
| Contrast dye for imaging (iodine-based) | 3,287 | $0 | $3 |
| Dexamethasone injection (steroid) | 1,175 | $0 | $1 |
| Blood draw (venipuncture) | 1,148 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,057 | $8 | $36 |
| Office visit, established patient (30-39 min) | 809 | $90 | $368 |
| Comprehensive metabolic blood panel | 657 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 510 | $1 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 317 | $45 | $313 |
| Ferritin level test (iron stores) | 304 | $13 | $60 |
| Iron level test | 303 | $6 | $27 |
| Iron binding capacity test | 303 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 262 | $21 | $157 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 171 | $272 | $2,762 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 163 | $15 | $100 |
| Injection, zoledronic acid, 1 mg | 153 | $5 | $431 |
| Immunoglobulin level test | 126 | $9 | $56 |
| Administration of chemotherapy into vein, 1 hour or less | 126 | $97 | $707 |
| Drug injection, under skin or into muscle | 114 | $10 | $96 |
| Injection, diphenhydramine hcl, up to 50 mg | 108 | $1 | $7 |
| Vitamin B-12 level test | 90 | $15 | $76 |
| Microscopic examination for white blood cells with manual cell count | 71 | $4 | $22 |
| Complete blood count (CBC), automated | 71 | $6 | $34 |
| Infusion, normal saline solution , 1000 cc | 68 | $2 | $19 |
| Measurement of immunoglobulin light chains | 62 | $17 | $60 |
| Office visit, established patient (10-19 min) | 52 | $41 | $150 |
| New patient office visit (45-59 min) | 44 | $115 | $565 |
| Magnesium level test | 38 | $7 | $29 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 34 | $1,160 | $4,802 |
| Office visit, established patient (20-29 min) | 33 | $49 | $250 |
| Injection of additional new drug or substance into vein | 32 | $11 | $108 |
| Lactate dehydrogenase (enzyme) level | 30 | $6 | $31 |
| Ct scan of chest with contrast | 29 | $40 | $821 |
| CT scan of abdomen and pelvis with contrast | 29 | $149 | $1,067 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | $91 | $657 |
| Blood creatinine level | 21 | $5 | $31 |
| Folic acid level test | 16 | $14 | $73 |
| CT scan of chest, without contrast | 14 | $32 | $686 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
11.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bejjanki is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bejjanki experienced with iron sucrose injection (venofer)?
Does Dr. Bejjanki receive payments from pharmaceutical companies?
How do Dr. Bejjanki's costs compare to other internal medicines in Cleburne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology